NBY News and Press, NovaBay Pharmaceuticals Inc. From 01/31/23

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 2:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website...

MONTREAL, Jan. 25, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce significant improvements in metallurgical testing on the known area of the Crevier Project. Historical work and latest re...

PhaseOne is uniquely formulated with NovaBay Pharmaceuticals’ unique and proprietary hypochlorous acid PhaseOne Health announces the expansion of its commercial program for PhaseOne Skin and Wound Care Cleanser through collaborative partnerships with innovative wound dressing man...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday! Moving stocks this morning are earnings reports, de...

Douyin, China’s TikTok counterpart, drives 26% increase in DERMAdoctor sales and 258% more visitors to its online stores during Double 11 event NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the expansion of its lifestyle promotional vide...

NovaBay Pharmaceuticals ( NYSE: NBY ) announced that the company’s common stock would start trading on a split-adjusted basis on Nov. 15 after the closing bell following a 1-for-35 reverse stock split. Accordingly, every 35 shares of NBY’s outstanding common ...

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2022 Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Confer...

NovaBay press release ( NYSE: NBY ): Q3 GAAP EPS of -$0.10. Revenue of $3.83M (+68.7% Y/Y) NovaBay had cash and cash equivalents of $3.9 million as of September 30, 2022, compared with $7.5 million as of December 31, 2021. For further details see: NovaBay GAA...

NovaBay ( NYSE: NBY ) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close. The consensus EPS Estimate is -$0.03 (+40.0% Y/Y) and the consensus Revenue Estimate is $3.74M (+103.3% Y/Y). Over the last 3 months, EPS estimates have see...

New super-charged serum helps men and women minimize the size of enlarged facial pores NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the newest addition to the DERMAdoctor ® Picture Porefect ® collection: 15% Niacinamide ...